Category Archives: Technology

GSK Signs $120M Deal to Market DMab Overseas

By George Koroneos | Published: July 29, 2009
Image via Wikipedia In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval. GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Also posted in Deals, News | Tagged , , , , , , , , , , , | Leave a comment

Daiichi Sankyo Chief Talks Effient

By George Koroneos | Published: July 15, 2009
FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a [...]
Also posted in News, Strategy | Tagged , , , , , , | 2 Comments

Live from DIA: Bridging the Data Gap

By George Koroneos | Published: June 24, 2009
Image via CrunchBase At the Drug Information Association’s annual meeting, Pharm Exec got a few minutes to talk with a little software company named Microsoft’s about its work in creating integration between electronic data capture [EDC] and electronic health records [EHR], and its new Amalga technology. Electronic Data Capture Integration “I don’t think electronic data capture has evolved [...]
Posted in Technology | Tagged , , , , | Leave a comment

Working Towards a Solution : An Interview with Oracle’s Neil de Crescenzo

By George Koroneos | Published: June 24, 2009
Just a few days shy of the one year anniversary of the launch of Oracle’s Health Sciences Global Business Unit, Neil de Crescenzo, senior vice president and general manager for the business unit sat down with Pharm Exec to talk about the future of clinical trial software and technology and the need for standards and [...]
Also posted in People, Strategy | Tagged , , , , , , , , | Leave a comment

AZ is All A-Twitter

By Brittany Agro | Published: February 11, 2009
When it comes to digital and social media, is Big Pharma finally getting it? Yesterday, AstraZeneca launched a branded YouTube channel for its asthma drug Symbicort, joining the ranks of Abbott, GSK, J&J, and most recently, Santofi-Aventis. This news arrived just in time for the 8th Annual ePharma Summit, where industry experts are gathered to [...]
Also posted in E-Media, Events | Tagged , , , | 1 Comment